aTyr Pharma, Inc. (ATYR) vs Cel-Sci Corporation (CVM)
aTyr Pharma, Inc. and Cel-Sci Corporation are both Biotechnology companies. aTyr Pharma, Inc. and Cel-Sci Corporation are of similar size ($31.4M and $30.3M). Cel-Sci Corporation grew revenue faster over the last twelve months: 20.8% against 6.78%. Across the 15 metrics below, aTyr Pharma, Inc. leads on 9 and Cel-Sci Corporation on 6.
Valuation
Profitability
| Metric | ATYR | CVM | Biotechnology median |
|---|---|---|---|
| Gross margin | 1.72% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (98.67%) | (252.53%) | (57.72%) |
| Return on assets | (70.97%) | (108.91%) | (49.22%) |
| Return on invested capital | 0.00% | (169.59%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack